CEO Per Jansson explains the outcome of two recent safety studies, the choice of making a private placement and Vicore Pharma’s development plans going forward.

Andreas Kvist

Equity Analyst

Sign up for free to continue.

Premium

Already a member?

Vicore Pharma: Video interview with CEO Per Jansson

Redeye Research Interview timeStamp 2017/04/10

Sign up for free to continue.

Tagged companies

You need to be a Redeye member to access this content

Become a member to:

Redeye Research Interview 2017/04/10